Prevalence of hypertension and obesity in patients with type 2 Diabetes Mellitus
DOI:
https://doi.org/10.1590/s2175-97902022e20497Keywords:
Chronic noncommunicable disease, Hyperglycemia, Hypertensive, Overweight, Educational practicesAbstract
Faced with the increase of type 2 Diabetes mellitus (DM2) and the failure in treatment, questions have been raised about the clinical situation of these patients. The present study analyzes the prevalence of hypertension and obesity in DM2 patients. Data were collected through interviews and anamnesis of 16 participants. After the meetings, in which capillary glycemia and blood pressure were measured, the participants received guidance about glycemic monitoring, blood pressure control and changes in lifestyle. Approximately 75% of the participants were women with average age of 65 years, 87.5% were sedentary, 18.75% smoked and/or used alcoholic beverages and none performed regular blood glucose monitoring. The initial blood glucose average was 148 mg/ dL and finally decreased to 133 mg/dL. There was no significant difference in blood pressure levels. Regarding the body mass index, 89.4% of the patients were above normal standards and 100% had altered waist circumference values. There is a need for studies like this in order to promote educational practices for health and disease control, highlighting the importance of multidisciplinary teams and the pharmaceutical professional, since non-adherence to blood glucose monitoring, also associated with hypertension and obesity, can interfere with the individual’s clinical condition.
Downloads
References
ADA, American Diabetes Association. 6. Glycemic Targets: Standards of Medical Care in Diabetes-2020. Diabet Care. 2020;43(1):S66-S76.
Alayoub, H, Curran S, Coffey M, Hatunic M, Higgins M. Assessment of the effectiveness of group education on knowledge for women with newly diagnosed gestational diabetes. Ir J Med Sci (1971-). 2018;187(1):65-68.
Bernini LS, Barrile SR, Mangili AF, Arca EA, Correr R, Ximenes MA, et al. O impacto do Diabetes Mellitus na qualidade de vida de pacientes da Unidade Básica de Saúde. Cad Bras Ter Ocup. 2017;25(3):533-541.
Costa MM. A baixa adesão de pacientes hipertensos no programa hiperdia, um problema na unidade de saúde da família Lagoa das Flores, Vitória da Conquista-BA. [dissertation]. Campo Grande: Universidade Federal de Mato Grosso do Sul, Atenção Básica em Saúde da Família; 2013.
Daousi C, Casson IF, Gill GV, MacFarlane IA, Wilding JP, Pinkney JH. Prevalence of obesity in type 2 diabetes in secondary care: association with cardiovascular risk factors. Postgrad Med J. 2006;82(1):280-84.
Duarte APP, Rodrigues PRM, Ferreira MG, Cunha DB, Moreira NF, Sichieri R, et al. Socio-economic and demographic characteristics associated with risk behaviour patterns for chronic non-communicable diseases in Brazil: data from the National Health Survey, 2013. Public Health Nutr. 2019;22(11):2083-2091.
Fagundes CN, Corso ACT, González-Chica DA. Perfil Epidemiológico De Hipertensos E Diabéticos Cadastrados Na Atenção Básica Em Saúde, Florianópolis-Sc/ Epidemiological Profile Of Hypertensive And Diabetics Registered In Basic Health Care, Florianópolis-SC. Rev Pesq Saúde. 2017;18(1):28-34.
Francisco PMSB, Segri NJ, Borim FSA, Malta DC. Prevalência simultânea de hipertensão e diabetes em idosos brasileiros: desigualdades individuais e contextuais. Ciênc Saúde Colet. 2018; 23(11):3829-3840.
IDF, International Diabetes Federation. Diabetes Atlas - 8th Edition. Brussels: International Diabetes Federation; 2017.
Jardim TV, Inuzuka S, Galvão L, Negretto LAF, Oliveira RO, Sá WF, et al. Multidisciplinary treatment of patients with diabetes and hypertension: experience of a Brazilian center. Diabetol Metab Syndr. 2018;10(3):1-8.
Kahn SE, Cooper ME, Del Prato S. Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future. The Lancet. 2014;383(9922):1068-1083.
Laar AK, Adler AJ, Kotoh AM, Legido-Quigley H, LangeI L, Perel P, et al. Health system challenges to hypertension and related non-communicable diseases prevention and treatment: perspectives from Ghanaian stakeholders. BMC Health Serv Res. 2019;19(693):1-13.
Lee MK, Blumberg B. Transgenerational effects of obesogens. Basic Clin Pharmacol Toxicol. 2019;125(3):44-57.
Lima RF, Machado AV, Rebelo FM, Naves JDOS, Lavich TR, Dullius J. Interações medicamentosas potenciais em diabéticos tipo 2 participantes de um programa de educação em saúde. Infarma Ciências Farmacêuticas. 2015; 27(3):160-167.
Lima CR, Menezes IHCF, Peixoto MRG. Educação em saúde: avaliação de intervenção educativa com pacientes diabéticos, baseada na teoria social cognitiva. Ciênc Educ. 2018;24(1):141-156.
Maggio CA, Pi-Sunyer FX. Obesity and type 2 diabetes. Endocrinol Metab Clin North Am. 2003;32(1):805-822.
Malfatti CRM, Assunção AN. Hipertensão arterial e diabetes na estratégia de Saúde da Família: uma análise da frequência de acompanhamento pelas equipes de Saúde da Família. Ciênc Saúde Colet . 2011;16(1):1383-1388.
Malta DC, Bernal RTI, Souza MFM, Szwarcwald CL, Lima MG, Barros MBA. Social inequalities in the prevalence of self-reported chronic non-communicable diseases in Brazil: national health survey 2013. Int J Equity Health. 2016;15(153): 1-11.
Marinho NBP, Vasconcelos HCA, Alencar AMPG, Almeida PC, Damasceno MMC. Risk for type 2 diabetes mellitus and associated factors. Acta Paul Enferm. 2013;26(6):569-574.
Ministério da Saúde - Brasil [homepage on the internet]. Saúde: Hábitos dos brasileiros impactam no crescimento da obesidade e aumenta a prevalência de diabetes e hipertensão. 2017. [acess in 23 Mar 2020]. Avaiable link: Avaiable link: http://portalms.saude.gov.br
» http://portalms.saude.gov.br
Munger MA. Polypharmacy and Combination Therapy in the Management of Hypertension in Elderly Patients with Co-Morbid Diabetes Mellitus. Drugs Aging. 2010;27(1):871-883.
NCEP, National Cholesterol Education Program. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486-2497.
Noale M, Veronese N, Cavallo Perin P, Pilotto A, Tiengo A, Crepaldi G, Maggi S. Polypharmacy in elderly patients with type 2 diabetes receiving oral antidiabetic treatment. Acta Diabetol. 2016;53(1):323-330.
Ormazabal V, Nair S, Elfeky O, Aguayo C, Salomon C, Zuñiga FA. Association between insulin resistance and the development of cardiovascular disease. Cardiovasc Diabetol. 2018;17(122):1-14.
Petrie JR, Guzik TJ, Touyz RM. Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms. Can J Cardiol. 2018;34(5):575-584.
Pinho L, Aguiar APS, Oliveira MR, Barreto NAP, Ferreira CMM. Hipertensão e dislipidemia em pacientes diabetes mellitus tipo 2: uma revisão integrativa. Renome. 2015;4(1):87-101.
Porto EF, Souza JDS, Marques NDM. Frequency of Stroke and Cardiovascular Events in Diabetic and Hypertensive Patients - Follow up 15 years. J Diab Obes Metab. 2020;3(1):116.
Ralston J, Brinsden H, Buse K, Candeias V, Caterson I, Hassell T, et al. Time for a new obesity narrative. Lancet. 2018;392(10156):1384-1386.
Rocha NS, Souza MP, de Oliveira Paegle ACR, dos Santos ACO. Avaliação do controle glicêmico pela glicemia capilar de usuários diabéticos tipo 2, em um serviço de atenção básica no município de Recife. Ciênc Biol Saúd Unit. 2017; 3(1): 75-86.
Salinero-Fort MA, Pau ECS, Arrieta-Blanco FJ, Abanades-Herranz JC, Martín-Madrazo C, Rodés-Soldevila B, et al. Effectiveness of PRECEDE model for health education on changes and level of control of HbA1c, blood pressure, lipids, and body mass index in patients with type 2 Diabetes Mellitus BMC Public Health. 2011;11(267):1-9.
Santos PCJL. Atenção farmacêutica: contexto atual, exames laboratoriais e acompanhamento farmacoterapêutico. 1 Edition. São Paulo: Atheneu; 2016.
SBC Diretrizes, Sociedade Brasileira de Cardiologia [homepage on the internet]. Conceituação, epidemiologia e prevenção primária. 2017. [acess in 15 apr 2020]. Avaiable link: Avaiable link: http://www.departamentos.cardiol.br
» http://www.departamentos.cardiol.br
SBD Diretrizes, Sociedade Brasileira de Diabetes [homepage on the internet]. 2019-2020. [acess in 27 May 2020]. Avaiable link: Avaiable link: https://www.diabetes.org.br/
» https://www.diabetes.org.br/
SBD Diretrizes, Sociedade Brasileira de Diabetes [homepage on the internet]. Classificação etiológica do Diabetes Mellitus 2014-2015. [acess in 13 feb 2020]. Avaiable link: Avaiable link: http://www.diabetes.org.br
Schlichthorst M, Sanci LA, Pirkis J, Spittal MJ, Hocking JS. Why do men go to the doctor? Socio-demographic and lifestyle factors associated with healthcare utilisation among a cohort of Australian men. BMC Public Health . 2016;16(1028):81-90.
Schmidt MI, Duncan BB, Silva GA, Menezes AM, Monteiro CA, Barreto SM, et al. Chronic non-communicable diseases in Brazil: burden and current challenges. Lancet . 2011;377(9781):1949-1961.
Secoli SR. Polifarmácia: interações e reações adversas no uso de medicamentos por idosos. Rev Bras Enferm., 2010;63(1):136-140.
Silva DF, Araújo NCS, Campos EAD. Perfil dos pacientes hipertensos e diabéticos atendidos na Atenção Básica. REFACI. 2018;2(2):1-11.
Silva MDCC, de Araújo Soares K, Leal CS, da Silva DV, da Rocha Filho DR. Avaliação epidemiológica dos pacientes diabetes mellitus e hipertensão arterial. JIBI. 2018;3(1):25-30.
Silveira EA, Vieira LL, Jardim TV, Souza JD. Obesidade em Idosos e sua Associação com Consumo Alimentar, Diabetes Mellitus e Infarto Agudo do Miocárdio. Arq. Bras Cardiol. 2016;107(6):509-517.
Tschiedel B. Complicações Crônicas do Diabetes. JMB. 2014;102(5):7-11.
Upadhyay J, Farr O, Perakakis N, Ghaly W, Mantzoros C. Obesity as a Disease. Med Clin North Am. 2018;102(1):13-33.
Vitória AG, Guandalini VR. Qualidade da dieta e estado nutricional de diabéticos tipo 2 atendidos na atenção primária do município de Vitória, Espírito Santo. Rev Baiana Saúde Pública. 2016;40(4):909-923.
Veronin MA. An atypical case of extreme polypharmacy. Drug Healthc Patient Saf. 2022;14:19-26.
WHO, World Health Organization [homepage on the internet] Physical status: the use of and interpretation of anthropometry, report of a WHO expert committee. World Health Organization. 1995. [Acess in 10 feb 2020]. Link: avaiable Link: avaiable https://apps.who.int/iris/handle/10665/37003
» https://apps.who.int/iris/handle/10665/37003
Wilding JPH. The importance of weight management in type 2 diabetes mellitus. Int J Clin Pract. 2014;68(6):682-691.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Brazilian Journal of Pharmaceutical Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content of the journal, except where identified, is licensed under a Creative Commons attribution-type BY.
The on line journal has open and free access.
